Similar articles

• Atrial Fibrillation and Cancer-Validation in the Real World.

  Kim CH, Al-Kindi SG, Oliveira GH. Kim CH, et al. JAMA Cardiol. 2017 Mar 1;2(3):343-344. doi: 10.1001/jamacardio.2016.3981. JAMA Cardiol. 2017. PMID: 27851852 No abstract available.
• Stroke prevention in atrial fibrillation – latest guideline recommendations and real world data.

  Johnson V, Schmitt J, Hamm CW. Johnson V, et al. Med Monatsschr Pharm. 2017 Apr;40(4):167-70. Med Monatsschr Pharm. 2017. PMID: 29952167 Review. English, German.
• Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.

  Arihiro S, Todo K, Koga M, Furui E, Kinoshita N, Kimura K, Yamagami H, Terasaki T, Yoshimura S, Shiokawa Y, Kamiyama K, Takizawa S, Okuda S, Okada Y, Nagakane Y, Kameda T, Hasegawa Y, Shibuya S, Ito Y, Nakashima T, Takamatsu K, Nishiyama K, Matsuki T, Homma K, Takasugi J, Tokunaga K, Sato S, Kario K, Kitazono T, Toyoda K; SAMURAI Study Investigators. Arihiro S, et al. Int J Stroke. 2016 Jul;11(5):565-74. doi: 10.1177/1747493016632239. Epub 2016 Feb 29. Int J Stroke. 2016. PMID: 26927811
• Gastrointestinal Bleeding and Direct Oral Anticoagulants Amongst Patients With Atrial Fibrillation in the "Real World".

  Mazurek M, Lip GYH. Mazurek M, et al. Gastroenterology. 2017 Apr;152(5):932-934. doi: 10.1053/j.gastro.2017.02.027. Epub 2017 Mar 1. Gastroenterology. 2017. PMID: 28259717 No abstract available.
• Cancer, atrial fibrillation, and stroke.

  Fitzpatrick T, Carrier M, Le Gal G. Fitzpatrick T, et al. Thromb Res. 2017 Jul;155:101-105. doi: 10.1016/j.thromres.2017.05.006. Epub 2017 May 9. Thromb Res. 2017. PMID: 28528288 Review.